MEDICUS PHARMA LTD (MDCX) Stock Income Statement
NASDAQ:MDCX - Nasdaq - CA58471K2020 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 10.96M | 11.18M | 2.66M | 978.40K | 141.70K | |||
| Research and Development | 2.20M | 3.53M | 193.60K | 646.40K | N/A | |||
| Selling, General, and Administrative Expenses | 8.68M | 7.65M | 2.46M | 332.00K | 141.70K | |||
| Operating Income | -10.96M | -11.18M | -2.66M | -978.40K | -141.70K | |||
| Interest Income/Expense | -50.80K | 25.40K | -584.80K | -526.80K | N/A | |||
| Other Income/Expense | N/A | N/A | N/A | -187.10K | N/A | |||
| Non Recurring Items | N/A | 0.00 | -2.07M | 0.00 | N/A | |||
| Income Before Taxes | -11.73M | -11.16M | -5.31M | -1.69M | -141.70K | |||
| Net Income | -11.73M | -11.16M | -5.31M | -1.69M | -141.70K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.39 | -1.16 | -1.53 | -0.90 | -0.04 | |||
| Non GAAP EPS | -2.32 | -2.01 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD